Geneos Wealth Management’s Hull Tactical US ETF HTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$407K Buy
9,272
+3,673
+66% +$156K 0.01% 802
2026
Q1
$214K Hold
5,599
0.01% 938
2025
Q4
$222K Buy
5,599
+1,552
+38% +$66.9K 0.01% 895
2025
Q3
$173K Sell
4,047
-353
-8% -$14.5K ﹤0.01% 948
2025
Q2
$176K Buy
4,400
+99
+2% +$3.66K ﹤0.01% 1044
2025
Q1
$157K Buy
4,301
+746
+21% +$28.4K 0.01% 1007
2024
Q4
$135K Buy
+3,555
New +$160K ﹤0.01% 967

Other funds holding HTUS

Geneos Wealth Management's HTUS Position: Q2 2026 in Review

Geneos Wealth Management increased its Hull Tactical US ETF (HTUS) stake by 66% in Q2 2026, buying an estimated $156K and bringing the position to 9,272 shares worth $407K. The position accounts for 0.01% of the portfolio, ranked #802.

Geneos Wealth Management first reported a position in HTUS in Q4 2024 and has held it in 7 quarters since. 28 funds tracked by Wall St. Rank hold HTUS as of Q2 2026.

  • Geneos Wealth Management held 9,272 shares of Hull Tactical US ETF worth $407K as of Q2 2026.
  • Geneos Wealth Management bought 3,673 Hull Tactical US ETF shares in Q2 2026, an estimated $156K.
  • Hull Tactical US ETF made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #802 holding.
  • Geneos Wealth Management first reported a position in Hull Tactical US ETF in Q4 2024 and has held it in 7 quarters since.
  • 28 funds tracked by Wall St. Rank held Hull Tactical US ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.